Trials / Completed
CompletedNCT06004375
THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Universitas Sriwijaya · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to determine effect of arginine and glutamine on outcome of COVID-19 patients. The main questions it aims to answer are: -to test the effect of oral nutritional supplements containing arginine and glutamine on covid-19 patients outcome Dr. M. Djamil General Hospital Padang Participants will given ONS containing arginine and glutamine. Researchers will compare intervention group with control group to see if ONS affected outcome of COVID-19 patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Neomune | Neomune containing 4.8 g arginine and 2 g glutamine |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2023-05-30
- Completion
- 2023-05-30
- First posted
- 2023-08-22
- Last updated
- 2023-08-22
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT06004375. Inclusion in this directory is not an endorsement.